Cartesian Therapeutics, Inc. (RNAC)

8.505 +0.66 (+8.34%) USD  |  NASDAQ  |  Dec 11, 16:00
8.505 0.00 (0.00%) After-Hours: 20:00
More

Cartesian Therapeutics Free Cash Flow: -52.84M for June 30, 2025

Free Cash Flow Chart

View Free Cash Flow for RNAC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Repligen Corp. 103.47M
Cabaletta Bio, Inc. -120.26M
Arcellx, Inc. -201.18M
NovaBay Pharmaceuticals, Inc. -7.012M
Palatin Technologies, Inc. -15.91M

Free Cash Flow Related Metrics

Free Cash Flow Per Share (Quarterly) -0.7606
Free Cash Flow to Equity (Quarterly) -19.40M
Free Cash Flow to Firm (Quarterly) -20.12M
Free Cash Flow Yield -24.90%